Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Peginterferon alfa-2a Pegasys
Peginterferon alfa-2b PegIntron
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviSection Navigation
Section Navigation
- Module 5 Overview
Treatment of Chronic Hepatitis C Infection - 0%Lesson 1
Treatment of HCV Genotype 1Activities- 1A.Core Concepts
- 1B.AASLD-IDSA Hepatitis C Guidance
- 1C.Choices for Initial Treatment of Patients with Genotype 1a Chronic HCV
- 0%Lesson 2
Treatment of HCV Genotype 2Activities- 0%Lesson 3
Treatment of HCV Genotype 3Activities- 0%Lesson 4
Treatment of HCV Genotype 4Treatment of Chronic Hepatitis C Infection Overview3rd Edition
Module Core Competency
Apply Evidence-Based Treatment of Chronic Hepatitis C Infection
Target Audience
For clinicians treating chronic hepatitis C infection. Material covered includes recommendations for treatment-naïve and treatment-experienced persons with chronic HCV infection genotypes 1-6, based on the Association for the Study of Liver Diseases and Infectious Diseases Society of America (AASLD-IDSA) HCV Guidance.Editors
David H. Spach, MD,David H. Spach, MD
Professor of Medicine
Division of Infectious Diseases
University of WashingtonDisclosures: NoneH. Nina Kim, MDH. Nina Kim, MD
Associate Professor of Medicine
Division of Infectious Diseases
University of WashingtonDisclosures: NoneFree CE CNE/CME
Available in theTreatment of Chronic Hepatitis C Infection Self-Study Module
Module Lessons
1Lesson 1 Treatment of HCV Genotype 1
- Learning Objectives
- List key factors that influence the choice and duration of therapy for treating HCV genotype 1 infection
- Describe the circumstances for NS5A genotypic drug resistance testing
- Discuss preferred therapies for initial treatment of treatment-naïve adults with HCV genotype 1 infection
- List the preferred therapies for retreatment of adults with chronic HCV genotype 1 infection who have previously failed therapy
- Quick ReferenceTreatment of HCV Genotype 1 Core Concepts
- Activity 1B.AASLD-IDSA Hepatitis C Guidance
- Activity 1C.Choices for Initial Treatment of Patients with Genotype 1a Chronic HCV
2Lesson 2 Treatment of HCV Genotype 2
- Learning Objectives
- List preferred therapies for initial treatment of adults with HCV genotype 2 chronic infection
- Describe the preferred therapy for retreatment of adults with HCV genotype 2 chronic infection who have failed prior therapy
- Quick ReferenceTreatment of HCV Genotype 2 Core Concepts
3Lesson 3 Treatment of HCV Genotype 3
- Learning Objectives
- List preferred therapies for initial treatment of adults with HCV genotype 3 chronic infection
- Describe the preferred therapy for retreatment of adults with HCV genotype 3 chronic infection who have failed prior therapy
- Quick ReferenceTreatment of HCV Genotype 3 Core Concepts
4Lesson 4 Treatment of HCV Genotype 4
- Learning Objectives
- Understand the preferred therapies for the initial treatment of adults with HCV genotype 4 chronic infection
- State the preferred therapy for retreatment of adults with HCV genotype 4 chronic infection in whom prior therapy has failed
- Quick ReferenceTreatment of HCV Genotype 4 Core Concepts
5Lesson 5 Treatment of HCV Genotype 5 or 6
- Learning Objectives
- List the preferred therapies for the initial treatment of adults with HCV genotype 5 or 6 chronic infection
- Discuss the preferred approach to retreatment of adults with HCV genotype 5 or 6 chronic infection who have failed prior therapy
- Quick ReferenceTreatment of HCV Genotype 5 or 6 Core Concepts
- Activity 5B.NATAP Web Site
6Lesson 6 Monitoring During and After HCV Treatment
- Learning Objectives
- List the recommended monitoring for treatment efficacy and safety in adults receiving HCV therapy
- Discuss monitoring for hepatitis B virus reactivation during HCV therapy
- Summarize appropriate monitoring for patients after HCV treatment
- Quick ReferenceMonitoring During and After HCV Treatment Core Concepts
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA- PS16-1608)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
Copyright © 2021 Hepatitis C Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: 2.14.1